Nostos Genomics

🚀 Stand Out in the Genetic Testing Market – Join Our Co-founder Rocío Acuña Hidalgo and Head of Product Pablo Botas in our Webinar! "Lessons from Differentiating as a Genetic Testing Lab through Expertise: A Fireside Chat with Lorenzo Monserrat" In a crowded genetic testing market where pricing is the key competing factor, standing out is crucial yet challenging. What can be viable differentiation avenues for labs? Discover how Lorenzo Monserrat, Co-founder of DILEMMA Solutions and HealthInCode, established one of the world's leading labs in genetic testing for cardiac disease by leveraging unparalleled internal expertise and processes. Gain valuable business insights on building a reputation through quality, innovation, and specialized knowledge. If you’re involved in genetic testing and seeking ways to enhance your lab’s offering and differentiate your services, this session is for you and may help you draw insights to define your own path. 📅 Date: Tuesday, 19th November 2024 🕒 Time: 11:00 AM CET 👉 Register now: https://lnkd.in/ekvf7FWh We look forward to seeing you there! #GeneticTesting #Genomics #Webinar #LaboratoryExcellence #PrecisionMedicine #NostosGenomics

🚨 Last Chance to Register! Join Our Live Demo tomorrow. 🚨 📅 Date: Wednesday, November 6, 2024 🕒 Time: 11:00 am CET / 10:00 am GMT Don't miss this opportunity to see our AI-powered AION variant interpretation platform in action! Our experts, Aina Pi Roig and Pablo Botas, will lead an insightful session: 🔹 Demonstrating how using AI in variant interpretation can help uncover actionable genomic insights to confidently report pathogenic variants in complex cases. 🔹 Delving into the impact of AION prioritization capabilities, considering patients symptoms and exploring how our tool can facilitate deep reverse phenotyping and enhance the precision of rare disease diagnosis. 👉 Secure your spot now to gain insights into leveraging AI for streamlined, precise variant interpretation. Register here: https://lnkd.in/ecWMxUaE #GenomicDiagnostics #AIinHealthcare #VariantInterpretation #PrecisionMedicine #RareDiseases #NostosGenomics

Whole Exome Sequencing (WES) vs. Whole Genome Sequencing (WGS): which is better? In our latest blog article, our Co-Founder and CTO Rocío Acuña Hidalgo explores a case - a candidate pathogenic variant in MSH2 - where discrepancies in variant calls were found between Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) data. 👉 By comparing the data generated with both approaches, we highlight potential pitfalls in variant interpretation and offer insights into best practices for those clinical and research laboratories working with sequencing technologies. AI-driven tools like Nostos Genomics’ AION are changing the game - making WGS more accessible for diagnostics, reducing costs & increasing accuracy. Read more here: https://lnkd.in/eWiAWntd #Genomics #PrecisionMedicine #WGS #AI #HealthTech #Bioinformatics

📅 Don't forget to register for our Live demo and Q&A next week (6th November). 👇 Our team of experts Aina Pi Roig and Pablo Botas, will be on hand to showcase AION - Our AI-powered variant interpretation tool. 🔹 Presenting cases and demonstrating how using AI in variant interpretation can help uncover actionable genomic insights to confidently report pathogenic variants in complex cases. 🔹 Delving into the impact of AION prioritization capabilities, considering patients symptoms and exploring how our tool can facilitate deep reverse phenotyping and enhance the precision of rare disease diagnosis. 📅 Date: Wednesday 6th November, 2024 🕒 Time: 11:00 am CET / 10:00 am GMT 👉 Secure your spot now: https://lnkd.in/ecm4meMu

🔎 The primary goal of a genomic lab in diagnostics is to find answers. However, unnecessary complexities and inefficiencies from multiple analysis pipelines, can often divert valuable resources away from that goal. In our latest blog article, we explore how the introduction of secondary analysis as part of Nostos’ offering, facilitates an efficient end-to-end workflow from raw sequencing data to actionable clinical insights. A streamlined process which allows our customers to focus on finding the right answers for their cases faster! ⚡ Read more here: https://lnkd.in/evN22wSy #GenomicResearch #VariantScientists #IntegratedAnalysis #WorkflowOptimization #SecondaryAnalysis #VariantAnalysis

📅 Mark your calendars and join us for a Live demo and Q&A, with our team of experts Aina Pi Roig and Pablo Botas, showcasing and introducing you to AION - Our AI-powered variant interpretation tool. In this demo, you will: 🔹 Get to know AION and submit a case 🔹 See real-world examples of AION’s variant & disease prioritisation in action 🔹 Speak to our expert team, ask questions and find out how AION might be able to help you 📅 Date: Wednesday 6th November, 2024 🕒 Time: 11:00 am CET / 10:00 am GMT 👉 Secure your spot now: https://lnkd.in/eCyD5VHs Cannot attend? Register anyways and we'll send you a link of the recording to view at your convenience 👉 Register now: https://lnkd.in/eCyD5VHs #Genomics #VariantInterpretation #PrecisionMedicine #Bioinformatics #ClinicalGenomics #NGS

👀 A new large-scale study by the Wellcome Sanger Institute highlights the benefits of genetic diagnosis for children with severe developmental disorders. The research, part of the Deciphering Developmental Disorders (DDD) study, has already delivered life-changing answers for thousands of families, offering crucial insights into rare conditions that were previously undiagnosed. The findings demonstrate the power of genomic testing in transforming rare disease care and the importance in having a definitive molecular diagnosis.. 🧬 🔍 Learn more about the impact of this study here: https://lnkd.in/e3x-QPTi 👇 #Genomics #SangerInstitute #Diagnostics

🔎 Is your lab's variant interpretation taking too long and costing too much? Accelerate your workflow with our AI-driven variant prioritisation — the fastest way to pinpoint relevant variants in just 5-10 minutes, starting at €35 per case. 🌟 Boost Productivity: Reduce manual workload and streamline your workflow. 🌟 Enhance Accuracy: Rely on precise, reliable results for better patient outcomes. 🌟 Optimise Costs: Reduce operational costs without compromising quality Let's optimise your diagnostic workflow together. 🎉 Get in touch to learn more! https://lnkd.in/epaHR3J8

We’re thrilled to share our collaboration with the INSTITUTO CHROMOMED - A collaboration which reflects our mission at Nostos to transform genetic data into better patient outcomes. As Dr. Bary G. Bigay, MD. MSc. Scientific Director at the INSTITUTO CHROMOMED highlights: "We consider AION to be an exceptional variant interpreter, surpassing the alternatives currently available on the market. We believe this collaboration could be very beneficial and we look forward to working together” Stay tuned for more updates as we embark on this exciting journey together! 🌟 https://lnkd.in/e8xX7ZjJ #GenomicResearch #VariantScientists #VariantAnalysis #Genomics #VariantInterpretation #PrecisionMedicine #Bioinformatics #ClinicalGenomics #NGS